Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kari Meehan"'
Autor:
Terrence M. Katona, Justin D. Richey, Amanda J. Malek, Simon Warren, Liang Cheng, Theodore F. Logan, Kristin M. Post, Joshua R. Bradish, Joyashree D. Sen, Leslie A. Fecher, Kari Meehan
Publikováno v:
Modern Pathology. 28:480-486
Systemic targeted molecular therapy, in the form of a selective BRAF inhibitor with or without a MEK inhibitor, is a standard treatment for patients with BRAF V600 mutation-positive melanoma with unresectable stage III and IV disease. Patients with B
Autor:
Leticia Miravalle, Liang Cheng, Wenbin Huang, Kari Meehan, Anita J. Cornwell, Sarah A. Bilbo, Gregory T. MacLennan, Riley E. Alexander, Kristin M. Post, Qiu Rao, Rodolfo Montironi, Antonio Lopez-Beltran, Joyashree D. Sen, Timothy D. Jones
Publikováno v:
Histopathology. 61:1036-1042
Alexander R E, Lopez-Beltran A, Montironi R, MacLennan G T, Post K M, Bilbo S A, Jones T D, Huang W, Rao Q, Sen J D, Meehan K, Cornwell A, Miravalle L & Cheng L (2012) Histopathology KRAS mutation is present in a small subset of primary urinary bladd
Autor:
Riley E, Alexander, Antonio, Lopez-Beltran, Rodolfo, Montironi, Gregory T, MacLennan, Kristin M, Post, Sarah A, Bilbo, Timothy D, Jones, Wenbin, Huang, Qiu, Rao, Joyashree D, Sen, Kari, Meehan, Anita, Cornwell, Leticia, Miravalle, Liang, Cheng
Publikováno v:
Histopathology. 61(6)
To determine whether KRAS mutations occur in primary bladder adenocarcinoma.Twenty-six cases of primary urinary bladder adenocarcinoma were analysed. DNA was extracted from formalin-fixed, paraffin-embedded tissue and amplified with shifted terminati
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.